3rd Annual Advances in Immuno-Oncology USA CongressOctober 2020 | San Diego, USA

An outstanding and comprehensive programme showcasing the key therapeutic strategies and technological advances impacting this marketplace

The Immuno-Oncology USA Congress includes...

Over 200 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools

Over 40 presentations and case studies focussed on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical research

PLUS interactive opportunities including:

  • Panel Discussions on Novel Therapeutic Targets in IO – Opportunities and Challenges and Technological Challenges in Clinical Studies
  • 3 roundtable discussions on key industry growth areas within immuno-oncology

Last Year's Agenda at a Glance

08 October 2019 – Day One

  • Discovery of Immuno-Oncology Therapies
  • Translational Immuno-Oncology

09 October 2019 – Day Two

  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Immuno-Oncology Clinical Research & Trials